Early Bird registration for Cytokines 2026 closes Friday, 26 June 2026 — that’s just days away. If you haven’t registered yet, now is the time. Members of The Cytokine Society receive discounted registration rates, so be sure to register now to lock in the best price before the deadline passes. [READ MORE]
If you’re already making the trip to Glasgow for Cytokines 2026, here’s a compelling reason to stay an extra day. The IFN-λ Satellite Workshop 2026 will be held on Thursday, October 22nd at the Cancer Research UK Scotland Institute (CRUK-Scotland) on the Garscube Estate in Bearsden, just outside the city [READ MORE]
Tony Reder, MD, Professor of Neurology at the University of Chicago, helped develop interferon-β1b — the first FDA-approved biologic therapy for multiple sclerosis. His research uncovered subnormal IFN signaling in MS patients, providing the biological rationale for IFN-beta treatment, and his lab continues to unravel the striking dysregulation of gene [READ MORE]
With abstract notifications going out mid-June and the scientific programme taking shape, now is the time to get excited about Cytokines 2026. The meeting (18–21 October, Scottish Event Campus, Glasgow) will feature plenary and parallel sessions led by field leaders, poster sessions designed for in-depth discussion, and – new this [READ MORE]
I am Tim Nice, Associate Professor of Molecular Microbiology and Immunology at Oregon Health & Science University in Portland, OR. I grew up in rural Wisconsin and like to think that my first training as a biologist came from working with my parents to raise sheep on our farm. I [READ MORE]
I am Hosu Kim, MD. I always make a point of listening to others and learning their perspectives and habits as much as I can. At present, I am conducting translational medicine research as a full-time graduate student at the Seoul National University College of Medicine. Leveraging my research experience [READ MORE]
I am Biljana Riemelmoser, a PhD student at the University of Geneva. My research focuses on skin immunology and the function of Interleukin-38, an understudied cytokine involved in immune barrier regulation. More broadly, I am interested in how host–microbiota interactions regulate skin homeostasis and shape barrier function. I am excited [READ MORE]
ClinicalTrials.gov ID NCT06363370 Sponsor Kexing Biopharm Co., Ltd. Information provided by Kexing Biopharm Co., Ltd. (Responsible Party) Last Update Posted 2024-04-12 Brief Summary To evaluate the efficacy and safety of interferon α1b (GB05) in the treatment of children under 2 years of age with respiratory syncytial virus infection. Detailed Description [READ MORE]
ClinicalTrials.gov ID NCT06368882 Sponsor First Affiliated Hospital of Wenzhou Medical University Information provided by First Affiliated Hospital of Wenzhou Medical University (Responsible Party) Last Update Posted 2024-04-16 Brief Summary This is a prospective, multicenter, open-label, non-randomized controlled real-world study to explore the efficacy and safety and to accumulate more evidence-based [READ MORE]
ClinicalTrials.gov ID NCT06419361 Sponsor First Affiliated Hospital of Chongqing Medical University Information provided by Xiaoyang Zhang, First Affiliated Hospital of Chongqing Medical University (Responsible Party) Last Update Posted 2025-06-04 Brief Summary Stimulator of interferon gene (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
